Physician profile
Abdul Ezeldin
NPI 1639129133
$18,891.07
in general payments reported to CMS, 2019-2025
42 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,610 · 2020: $2,472 · 2021: $2,470 · 2022: $3,893 · 2023: $2,468 · 2024: $3,445 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,755 · Travel and Lodging: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,754.77 |
| Travel and Lodging | $1,690.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,578.60 | 2021-2024 | Micra, Linq II, Mycarelink |
| Abbott Laboratories | $2,540.14 | 2019-2025 | Mitraclip, Gallant, Diamondback Coronary |
| Boston Scientific Corporation | $2,175.60 | 2019-2024 | Latitude Communicator Power Supply, Watchman Access System, Watchman Flx |
| Bard Peripheral Vascular, INC. | $1,343.95 | 2019-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Shockwave Medical, INC | $1,115.65 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $942.08 | 2021-2024 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Endologix LLC | $908.31 | 2022 | |
| Cook Medical LLC | $686.65 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $665.12 | 2019-2024 | |
| Inari Medical, INC. | $648.20 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $646.67 | 2019-2024 | |
| Penumbra, INC. | $539.52 | 2020-2023 | Indigo System |
| Cardiovascular Systems INC. | $429.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $412.93 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $400.20 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $395.20 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.81 | 2019-2024 | Lifevest |
| Philips North America LLC | $304.68 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $270.81 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Amgen INC. | $198.39 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $183.35 | 2019-2023 | Farxiga |
| Becton, Dickinson and Company | $181.08 | 2023 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Abiomed | $177.52 | 2020-2025 | Impella |
| Terumo Medical Corporation | $129.52 | 2019 | |
| Alnylam Pharmaceuticals INC. | $92.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.17 | 2021-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $74.66 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $63.92 | 2024 | Arcalyst |
| Stryker Corporation | $60.10 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Elutia, INC. | $59.05 | 2022-2023 | |
| Biosense Webster, INC. | $55.47 | 2022-2023 | Carto 3 |
| Heartflow, INC. | $44.14 | 2024 | |
| Cvrx, INC. | $33.61 | 2024 | Barostim Neo System |
| Scpharmaceuticals INC. | $27.49 | 2024 | |
| Baxter Healthcare | $19.65 | 2023 | Hillrom - Abpm 7100 Ambulatory Blood Pressure Monitor |
| Asahi Intecc USA, INC. | $18.62 | 2025 | Asahi Peripheral Vascular Wires |
| E.R. Squibb & Sons, L.L.C. | $18.56 | 2023 | |
| Astellas Pharma US INC | $17.71 | 2022 | |
| Angiodynamics, INC. | $12.63 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| G Medical Diagnostic Services, INC. | $12.37 | 2022 | |
| Venclose INC. | $4.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Ezeldin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.